Skip to main content
Log in

Resolution of salbutamol enantiomers in human urine by reversed-phase high performance liquid chromatography after derivatization with 2,3,4,6-tetra-O-acetyl-β-D-glycopyranosyl isothiocyanate

  • Research Articles
  • Published:
Archives of Pharmacal Research Aims and scope Submit manuscript

Abstract

A stereospecific HPLC method has been developed for the resolution of the enantiomers of salbutamol in human urine. After solid-phase extraction and derivatization with 2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyl isothiocyanate, the diastereomeric derivatives were resolved (Rs=1. 83) on 5 μm octadecylsilan column using 35% acetonitrile in 0.05M ammonium acetate buffer (pH=6) as a mobile phase with electrochemical detection. The diastereomeric derivatives were formed within 30 min. The detection limit of each enantiomer was 20 ng/ml (S/N=3).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References Cited

  • Adams, A. G. and Stewart, J. T., A high performance liquid chromatographic method for the determination of albuterol enatiomers in human serum using solid phase extraction and a Sumichiral-OA chiral stationary phase.J. Liq. Chromatogr., 16, 3863–3875 (1993).

    Article  CAS  Google Scholar 

  • Allenmark, S. G.,Chromatographic Enantioseparation: Methods and Applications, Ellis Horwood, Chichester, 1991.

    Google Scholar 

  • Ariens, E. J., Stereochemistry: A Source of problems in medicinal chemistry part I.Med. Res. Rev., 6, 451–466 (1986).

    Article  PubMed  CAS  Google Scholar 

  • Ariens, E. J., Stereochemistry in the analysis of drugaction. part II.Med. Res. Rev., 7, 367–387 (1987).

    Article  PubMed  CAS  Google Scholar 

  • Ariens, E. J., Racemic Therapeutics: A source of problems to chemists and physicians.Anal. Proc., 29, 232–234 (1992).

    CAS  Google Scholar 

  • Boulton, D. W. and Fawcett, J. P., Determination of salbutamol enantiomers in human plasma and urine by chiral high-performance liquid chromatography.J. Chromatogr. B. 672, 103–109 (1995).

    Article  CAS  Google Scholar 

  • Brittain, R. T., Farmer, J. B. and Marschall, R. J., Some observations on the β-adrenoceptor agonist property of the isomers of salbutamol.Br. J. Pharmacol., 48, 144–147 (1973).

    PubMed  CAS  Google Scholar 

  • Hartly, D. and Middlemiss, D., Absolute configuration of the optical isomers of salbutamol.J. Med. Chem., 14, 895–896 (1971).

    Article  Google Scholar 

  • Hawkins, C. J. and Klease, G. T., Relative potency of (−)- and (±)-salbutamol on gunea pig tracheal tissue.J. Med. Chem., 16, 856–857 (1973).

    Article  PubMed  CAS  Google Scholar 

  • He, L. and Stewart, J. T., A high performance liquid chromatographic method for the determination of albuterol enatiomers in human serum using solid phase extraction and chemical derivatization.Biomed. chromatogr., 6, 291–294 (1992).

    Article  PubMed  CAS  Google Scholar 

  • Monteagudo, F. S. E. and Havlik, I., The chirality of medicines.S. Afr. J. Sci., 87, 429–430 (1991).

    CAS  Google Scholar 

  • Seo, J. M. and Kim, K. H., Chiral separation of salbutamol enantiomers in human plasma.Arch. Pharm. Res., 17, 244–248 (1994).

    Article  CAS  Google Scholar 

  • Tan, Y. K. and Soldin, S. J., Analysis of salbutamol enantiomers in human urine by chiral high-performance liquid chromatography and preliminary studies related to the stereoselective disposition kinetics in man.J. Chromatogr., 422, 187–195 (1987).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kim, K.H., Kim, T.K. Resolution of salbutamol enantiomers in human urine by reversed-phase high performance liquid chromatography after derivatization with 2,3,4,6-tetra-O-acetyl-β-D-glycopyranosyl isothiocyanate. Arch. Pharm. Res. 21, 217–222 (1998). https://doi.org/10.1007/BF02974031

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02974031

Key words

Navigation